Report EU - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Sep 15, 2022

EU - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Pricing Plan

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service, Privacy Policy and Licenses. We'll occasionally send you account related emails.

EU: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2022

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the EU

The EU prophylactic medicaments containing insulin market declined slightly to $X in 2021, waning by -X% against the previous year. The market value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The level of consumption peaked at $X in 2015; however, from 2016 to 2021, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the EU

In value terms, prophylactic medicaments containing insulin production dropped to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2013 with an increase of X%. Over the period under review, production hit record highs at $X in 2015; however, from 2016 to 2021, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in the EU

In 2021, the amount of medicaments containing insulin but not antibiotics in measured doses exported in the European Union surged to X tons, increasing by X% compared with 2020 figures. The total export volume increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the exports hit record highs at X tons in 2019; however, from 2020 to 2021, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2021. Overall, exports, however, saw a perceptible setback. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. The level of export peaked at $X in 2014; however, from 2015 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

France was the main exporter of medicaments containing insulin but not antibiotics in measured doses in the European Union, with the volume of exports recording X tons, which was near X% of total exports in 2021. Denmark (X tons) ranks second in terms of the total exports with an X% share, followed by Italy (X%) and Germany (X%). Hungary (X tons) held a relatively small share of total exports.

Exports from France increased at an average annual rate of +X% from 2012 to 2021. At the same time, italy (+X%), hungary (+X%) and germany (+X%) displayed positive paces of growth. moreover, italy emerged as the fastest-growing exporter exported in the european union, with a cagr of +X% from 2012-2021. by contrast, denmark (-X%) illustrated a downward trend over the same period. From 2012 to 2021, the share of France and Italy increased by +X and +X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Germany ($X), France ($X) and Denmark ($X) were the countries with the highest levels of exports in 2021, together comprising X% of total exports. These countries were followed by Italy and Hungary, which together accounted for a further X, with a CAGR of +X%, recorded the highest growth rate of the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in the European Union stood at $X per ton in 2021, shrinking by -X% against the previous year. In general, the export price recorded a pronounced slump. The pace of growth was the most pronounced in 2013 an increase of X%. Over the period under review, the export prices attained the peak figure at $X per ton in 2014; however, from 2015 to 2021, the export prices stood at a somewhat lower figure.

Prices varied noticeably countryorigin: the country with the highest price was Germany ($X per ton), while Hungary ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Hungary (+X%), while the other leaders experienced a decline in the export price figures.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in the EU

In 2021, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported in the European Union; with an increase of X% compared with 2020. The total import volume increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin imports dropped modestly to $X in 2021. Total imports indicated a pronounced expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2016 indices. The growth pace was the most rapid in 2020 when imports increased by X%. As a result, imports attained the peak of $X, and then reduced in the following year.

Imports by Country

In 2021, France (X tons) was the key importer of medicaments containing insulin but not antibiotics in measured doses, mixing up X% of total imports. It was distantly followed by Denmark (X tons), Germany (X tons), Spain (X tons) and Hungary (X tons), together mixing up a X% share of total imports. Italy (X tons), Greece (X tons), Belgium (X tons), the Czech Republic (X tons), Romania (X tons), the Netherlands (X tons) and Poland (X tons) followed a long way behind the leaders.

France was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses imports, with a CAGR of +X% from 2012 to 2021. At the same time, the czech republic (+X%), greece (+X%), romania (+X%), belgium (+X%), hungary (+X%) and poland (+X%) displayed positive paces of growth. the netherlands and germany experienced a relatively flat trend pattern. by contrast, spain (-X%), denmark (-X%) and italy (-X%) illustrated a downward trend over the same period. While the share of France (+X p.p.) and Greece (+X p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Spain (-X p.p.), Italy (-X p.p.), Germany (-X p.p.) and Denmark (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, France ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in the European Union, comprising X% of total imports. The second position in the ranking was taken by Germany ($X), with a X% share of total imports. It was followed by Denmark, with a X% share.

In France, prophylactic medicaments containing insulin imports increased at an average annual rate of +X% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Germany (-X% per year) and Denmark (-X% per year).

Import Prices by Country

In 2021, the import price in the European Union amounted to $X per ton, shrinking by -X% against the previous year. In general, the import price continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2020 when the import price increased by X% against the previous year. As a result, import price reached the peak level of $X per ton, and then contracted rapidly in the following year.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was the Netherlands ($X per ton), while Spain ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by France (+X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in the the EU?
+
The countries with the highest volumes of prophylactic medicaments containing insulin consumption in 2021 were Germany, France and Spain, together comprising 68% of total consumption. These countries were followed by Poland, the Netherlands, Romania, Hungary, Portugal, Greece and Denmark, which together accounted for a further 25%.
What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in the the EU?
+
The countries with the highest volumes of prophylactic medicaments containing insulin production in 2021 were Germany, France and Spain, with a combined 68% share of total production. These countries were followed by Poland, the Netherlands, Romania, Hungary, Denmark and Portugal, which together accounted for a further 24%.
What are the leading exporters of medicaments containing insulin but not antibiotics in measured doses in the the EU?
+
In value terms, the largest prophylactic medicaments containing insulin supplying countries in the European Union were Germany, France and Denmark, with a combined 86% share of total exports. Italy and Hungary lagged somewhat behind, together accounting for a further 11%.
What are the leading importers of medicaments containing insulin but not antibiotics in measured doses in the the EU?
+
In value terms, France constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in the European Union, comprising 47% of total imports. The second position in the ranking was held by Germany, with a 15% share of total imports. It was followed by Denmark, with a 5.9% share.
What is the average export price for medicaments containing insulin but not antibiotics in measured doses in the the EU?
+
The export price in the European Union stood at $345,275 per ton in 2021, waning by -9.2% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in measured doses in the the EU?
+
The import price in the European Union stood at $261,039 per ton in 2021, declining by -25.1% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Production in the EU, split by region and country
• Trade (exports and imports) in the EU
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
CONSUMPTION BY COUNTRY
3.3
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
7.2
PRODUCTION BY COUNTRY
8. IMPORTS

The Largest Importers on The Market and How They Succeed

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Exporters on The Market and How They Succeed

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

11. COUNTRY PROFILES

The Largest Markets And Their Profiles

• Austria
• Belgium
• Bulgaria
• Croatia
• Cyprus
• Czech Republic
• Denmark
• Estonia
• Finland
• France
• Germany
• Greece
• Hungary
• Ireland
• Italy
• Latvia
• Lithuania
• Luxembourg
• Malta
• Netherlands
• Poland
• Portugal
• Romania
• Slovakia
• Slovenia
• Spain
• Sweden
LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption, By Country, 2015–2021
Table 5:
Production, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Physical Terms, By Country, 2012–2021
Table 7:
Imports, In Value Terms, By Country, 2012–2021
Table 8:
Import Prices, By Country Of Destination, 2012–2021
Table 9:
Exports, In Physical Terms, By Country, 2012–2021
Table 10:
Exports, In Value Terms, By Country, 2012–2021
Table 11:
Export Prices, By Country Of Origin, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Consumption, By Country, 2021
Figure 4:
Market Forecast To 2030
Figure 5:
Products: Market Size And Growth, By Type
Figure 6:
Products: Average Per Capita Consumption, By Type
Figure 7:
Products: Exports And Growth, By Type
Figure 8:
Products: Export Prices And Growth, By Type
Figure 9:
Production Volume And Growth
Figure 10:
Exports And Growth
Figure 11:
Export Prices And Growth
Figure 12:
Market Size And Growth
Figure 13:
Per Capita Consumption
Figure 14:
Imports And Growth
Figure 15:
Import Prices
Figure 16:
Production, In Physical Terms, 2012–2021
Figure 17:
Production, In Value Terms, 2012–2021
Figure 18:
Production, By Country, 2021
Figure 19:
Production, In Physical Terms, By Country, 2012–2021
Figure 20:
Imports, In Physical Terms, 2012–2021
Figure 21:
Imports, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, By Country, 2021
Figure 23:
Imports, In Physical Terms, By Country, 2012–2021
Figure 24:
Imports, In Value Terms, By Country, 2012–2021
Figure 25:
Import Prices, By Country, 2012–2021
Figure 26:
Exports, In Physical Terms, 2012–2021
Figure 27:
Exports, In Value Terms, 2012–2021
Figure 28:
Exports, In Physical Terms, By Country, 2021
Figure 29:
Exports, In Physical Terms, By Country, 2012–2021
Figure 30:
Exports, In Value Terms, By Country, 2012–2021
Figure 31:
Export Prices, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET